Flurpiridaz F 18 PET: Phase II Safety and Clinical Comparison with SPECT Myocardial Perfusion Imaging for Detection of Coronary Artery Disease

OBJECTIVES: Phase II trial to assess flurpiridaz F 18 for safety and compare its diagnostic performance for PET myocardial perfusion imaging (MPI) to Tc-99m SPECT-MPI regarding image quality, interpretative certainty, defect magnitude and detection of coronary artery disease (CAD)(≥ 50% stenosis) on...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Coll Cardiol
Autori principali: Berman, Daniel S., Maddahi, Jamshid, Tamarappoo, B. K., Czernin, Johannes, Taillefer, Raymond, Udelson, James E., Gibson, C. Michael, Devine, Marybeth, Lazewatsky, Joel, Bhat, Gajanan, Washburn, Dana
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4316725/
https://ncbi.nlm.nih.gov/pubmed/23265345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.11.022
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi